Skip to main content

FDA recall, , High risk

123Herbals Silintan 25 Pills

Silintan capsules contain undeclared meloxicam, which can cause serious life-threatening events.

What happened

ANTHONY TRINH, 123Herbals LLC of Rosemead, California, is voluntarily recalling all lots of SILINTAN 25/pills, packaged in a 25-count bottle, to the consumer level. The product was marketed without an approved NDA/ANDA, and FDA analysis revealed the presence of undeclared meloxicam. The capsules, distributed nationwide in the USA, were from Shanghai Chinese Medical Works, Shanghai, China.

The company began the recall on October 20, 2025, and announced it on January 7, 2026. The recall was added to FDA's Enforcement Report on February 27, 2026, and included in the weekly enforcement report on March 11, 2026.

What to do

If you have this product:

  1. Consumers and retailers that have Silintan capsules, which is being recalled, should stop using this product and/or return to the place of purchase, discard, or contact their doctor.
  2. Consumers with questions regarding this recall can contact Anthony Trinh, 123Herbals LLC by email at hello@123herbals.com or via phone at 1-626-656-3202, Monday - Friday 8am-5pm Pacific Time.
  3. Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.
  4. You can return their product to the point of purchase for a refund. Customers that bought from the website 123Herbals.com can return to 300 West Valley Blvd.

Is yours affected?

Every lot is recalled. There's no code to check.

The company's latest announcement of January 7, 2026 covers all lots, so no lot or date is listed here.

  1. SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

Recall details

Company began the recall
Sold in

USA nationwide

Company
ANTHONY TRINH, 123Herbals LLCRosemead, California
Risk

High risk

There is a reasonable chance that taking it could cause serious health problems or death.

FDA Class I recall · How risk is rated

Event ID
98258
Recall number
D-0388-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Announced by the company

  3. Added to FDA's Enforcement Report

  4. In FDA's weekly enforcement report

  5. Classified by FDA

  6. Listed on Recall Canary

  7. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 24, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)